“Hypertriglyceridemia: From Biochemical Aberration to Cardiometabolic Syndrome - Emerging Pathophysiology, Clinical Challenges, and Novel Therapeutics ”. Diabzen 3, no. 2 (November 15, 2025): 11–15. Accessed February 27, 2026. https://www.thediabzen.com/index.php/d/article/view/12.